Class A1 scavenger receptors in cardiovascular diseases

British Journal of Pharmacology

Volumn 172, Issue 23, 2015, Pages 5523-5530

  Ben, Jingjing ^a   Zhu, Xudong ^a   Zhang, Hanwen ^a   Chen, Qi ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; LOW DENSITY LIPOPROTEIN; PATTERN RECOGNITION RECEPTOR; SCAVENGER RECEPTOR A; SCAVENGER RECEPTOR A1; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; UNCLASSIFIED DRUG;

ALPHA HELIX; AMINO ACID COMPOSITION; ANTIINFLAMMATORY ACTIVITY; ATHEROSCLEROSIS; CARBOXY TERMINAL SEQUENCE; CARDIOVASCULAR DISEASE; CELL ACTIVITY; CEREBROVASCULAR DISEASE; DRUG TARGETING; ENDOCYTOSIS; HEART ATRIUM REMODELING; HEART VENTRICLE REMODELING; HYPERLIPIDEMIA; LIGAND BINDING; MACROPHAGE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; PROTEIN TARGETING; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; SR A1 GENE; AGONISTS; ANIMAL; CARDIOVASCULAR DISEASES; CHEMISTRY; HUMAN; METABOLISM;

ANIMALS; CARDIOVASCULAR DISEASES; HUMANS; SCAVENGER RECEPTORS, CLASS A;

EID: 84935031646     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.13105     Document Type: Review

References (73)

1. Alexander SPH, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Spedding M, et al. (2013a). The Concise Guide to PHARMACOLOGY 2013/14: Catalytic Receptors. Br J Pharmacol 170: 1676-1705.
2. Alexander SPH, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Spedding M, et al. (2013b). The Concise Guide to PHARMACOLOGY 2013/14: Enzymes. Br J Pharmacol 170: 1797-1867.
3. Andersson L, Freeman MW, (1998). Functional changes in scavenger receptor binding conformation are induced by charge mutants spanning the entire collagen domain. J Biol Chem 273: 19592-19601.
4. Babaev VR, Gleaves LA, Carter KJ, Suzuki H, Kodama T, Fazio S, et al. (2000). Reduced atherosclerotic lesions in mice deficient for total or macrophage-specific expression of scavenger receptor-A. Arterioscler Thromb Vasc Biol 20: 2593-2599.
5. Ben J, Gao S, Zhu X, Zheng Y, Zhuang Y, Bai H, et al. (2009). Glucose-regulated protein 78 inhibits scavenger receptor A-mediated internalization of acetylated low density lipoprotein. J Mol Cell Cardiol 47: 646-655.
6. Ben J, Zhang Y, Zhou R, Zhang H, Zhu X, Li X, et al. (2013). Major vault protein regulates class A scavenger receptor-mediated tumor necrosis factor-α synthesis and apoptosis in macrophages. J Biol Chem 288: 20076-20084.
7. Bottalico LA, Wager RE, Agellon LB, Assoian RK, Tabas I, (1991). Transforming growth factor-beta 1 inhibits scavenger receptor activity in THP-1 human macrophages. J Biol Chem 266: 22866-22871.
8. Bowdish DM, Gordon S, (2009). Conserved domains of the class A scavenger receptors: evolution and function. Immunol Rev 227: 19-31.
9. Chen Y, Wang X, Ben J, Yue S, Bai H, Guan X, et al. (2006). The di-leucine motif contributes to class a scavenger receptor-mediated internalization of acetylated lipoproteins. Arterioscler Thromb Vasc Biol 26: 1317-1322.
10. Chen Y, Wermeling F, Sundqvist J, Jonsson AB, Tryggvason K, Pikkarainen T, et al. (2010). A regulatory role for macrophage class A scavenger receptors in TLR4-mediated LPS responses. Eur J Immunol 40: 1451-1460.
11. Coller SP, Paulnock DM, (2001). Signaling pathways initiated in macrophages after engagement of type A scavenger receptors. J Leukoc Biol 70: 142-148.
12. Devries-Seimon T, Li Y, Yao PM, Stone E, Wang Y, Davis RJ, et al. (2005). Cholesterol-induced macrophage apoptosis requires ER stress pathways and engagement of the type A scavenger receptor. J Cell Biol 171: 61-73.
13. Emi M, Asaoka H, Matsumoto A, Itakura H, Kurihara Y, Wada Y, et al. (1993). Structure, organization, and chromosomal mapping of the human macrophage scavenger receptor gene. J Biol Chem 268: 2120-2125.
14. Fong LG, Le D, (1999). The processing of ligands by the class A scavenger receptor is dependent on signal information located in the cytoplasmic domain. J Biol Chem 274: 36808-36816.
15. Fraser I, Hughes D, Gordon S, (1993). Divalent cation-independent macrophage adhesion inhibited by monoclonal antibody to murine scavenger receptor. Nature 364: 343-346.
16. Gao S, Zhong X, Ben J, Zhu X, Zheng Y, Zhuang Y, et al. (2009). Glucose regulated protein 78 prompts scavenger receptor A-mediated secretion of tumor necrosis factor-alpha by RAW 264.7 cells. Clin Exp Pharmacol Physiol 36: 940-944.
17. Geng YJ, Hansson GK, (1992). Interferon-gamma inhibits scavenger receptor expression and foam cell formation in human monocyte-derived macrophages. J Clin Invest 89: 1322-1330.
18. Goldstein JL, Ho YK, Basu SK, Brown MS, (1979). Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc Natl Acad Sci U S A 76: 333-337.
19. Gough PJ, Greaves DR, Gordon S, (1998). A naturally occurring isoform of the human macrophage scavenger receptor (SR-A) gene generated by alternative splicing blocks modified LDL uptake. J Lipid Res 39: 531-543.
20. Herijgers N, de Winther MP, Van Eck M, Havekes LM, Hofker MH, Hoogerbrugge PM, et al. (2000). Effect of human scavenger receptor class A overexpression in bone marrow-derived cells on lipoprotein metabolism and atherosclerosis in low density lipoprotein receptor knockout mice. J Lipid Res 41: 1402-1409.
21. Hohenester E, Sasaki T, Timpl R, (1999). Crystal structure of a scavenger receptor cysteine-rich domain sheds light on an ancient superfamily. Nat Struct Biol 6: 228-232.
22. Hsu HY, Nicholson AC, Hajjar DP, (1996). Inhibition of macrophage scavenger receptor activity by tumor necrosis factor-alpha is transcriptionally and post-transcriptionally regulated. J Biol Chem 271: 7767-7773.
23. Hsu HY, Hajjar DP, Khan KM, Falcone DJ, (1998). Ligand binding to macrophage scavenger receptor-A induces urokinase-type plasminogen activator expression by a protein kinase-dependent signaling pathway. J Biol Chem 273: 1240-1246.
24. Hsu HY, Chiu SL, Wen MH, Chen KY, Hua KF, (2001). Ligands of macrophage scavenger receptor induce cytokine expression via differential modulation of protein kinase signaling pathways. J Biol Chem 276: 28719-28730.
25. Hu Y, Zhang H, Lu Y, Bai H, Xu Y, Zhu X, et al. (2011). Class A scavenger receptor attenuates myocardial infarction-induced cardiomyocyte necrosis through suppressing M1 macrophage subset polarization. Basic Res Cardiol 106: 1311-1328.
26. Hughes DA, Fraser IP, Gordon S, (1994). Murine M phi scavenger receptor: adhesion function and expression. Immunol Lett 43: 7-14.
27. Ingersoll MA, Spanbroek R, Lottaz C, Gautier EL, Frankenberger M, Hoffmann R, et al. (2010). Comparison of gene expression profiles between human and mouse monocyte subsets. Blood 115: e10-e19.
28. Jones NL, Reagan JW, Willingham MC, (2000). The pathogenesis of foam cell formation: modified LDL stimulates uptake of co-incubated LDL via macropinocytosis. Arterioscler Thromb Vasc Biol 20: 773-781.
29. Kim S, Watarai M, Suzuki H, Makino S, Kodama T, Shirahata T, (2004). Lipid raft microdomains mediate class A scavenger receptor-dependent infection of Brucella abortus. Microb Pathog 37: 11-19.
30. Kim WS, Ordija CM, Freeman MW, (2003). Activation of signaling pathways by putative scavenger receptor class A (SR-A) ligands requires CD14 but not SR-A. Biochem Biophys Res Commun 310: 542-549.
31. Kodama T, Freeman M, Rohrer L, Zabrecky J, Matsudaira P, Krieger M, (1990). Type I macrophage scavenger receptor contains alpha-helical and collagen-like coiled coils. Nature 343: 531-535.
32. Kosswig N, Rice S, Daugherty A, Post SR, (2003). Class A scavenger receptor-mediated adhesion and internalization require distinct cytoplasmic domains. J Biol Chem 278: 34219-34225.
33. Krieger M, Herz J, (1994). Structures and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL receptor-related protein (LRP). Annu Rev Biochem 63: 601-637.
34. Kuchibhotla S, Vanegas D, Kennedy DJ, Guy E, Nimako G, Morton RE, et al. (2008). Absence of CD36 protects against atherosclerosis in ApoE knock-out mice with no additional protection provided by absence of scavenger receptor A I/II. Cardiovasc Res 78: 185-196.
35. Kunjathoor VV, Febbraio M, Podrez EA, Moore KJ, Andersson L, Koehn S, et al. (2002). Scavenger receptors class A-I/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages. J Biol Chem 277: 49982-49988.
36. Kzhyshkowska J, Neyen C, Gordon S, (2012). Role of macrophage scavenger receptors in atherosclerosis. Immunobiology 217: 492-502.
37. Lifshitz V, Weiss R, Levy H, Frenkel D, (2013). Scavenger receptor A deficiency accelerates cerebrovascular amyloidosis in an animal model. J Mol Neurosci 50: 198-203.
38. Loboda A, Jazwa A, Jozkowicz A, Molema G, Dulak J, (2006). Angiogenic transcriptome of human microvascular endothelial cells: effect of hypoxia, modulation by atorvastatin. Vascul Pharmacol 44: 206-214.
39. Lougheed M, Lum CM, Ling W, Suzuki H, Kodama T, Steinbrecher U, (1997). High affinity saturable uptake of oxidized low density lipoprotein by macrophages from mice lacking the scavenger receptor class A type I/II. J Biol Chem 272: 12938-12944.
40. Lu C, Hua F, Liu L, Ha T, Kalbfleisch J, Schweitzer J, et al. (2010). Scavenger receptor class-A has a central role in cerebral ischemia-reperfusion injury. J Cereb Blood Flow Metab 30: 1972-1981.
41. Lysko PG, Weinstock J, Webb CL, Brawner ME, Elshourbagy NA, (1999). Identification of a small-molecule, nonpeptide macrophage scavenger receptor antagonist. J Pharmacol Exp Ther 289: 1277-1285.
42. Ma K, Xu Y, Wang C, Li N, Li K, Zhang Y, et al. (2014). A crosstalk between class A scavenger receptor and receptor for advanced glycation end-products contributes to diabetic retinopathy. Am J Physiol Endocrinol Metab 307: E1153-E1165.
43. Manning-Tobin JJ, Moore KJ, Seimon TA, Bell SA, Sharuk M, Alvarez-Leite JI, et al. (2009). Loss of SR-A and CD36 activity reduces atherosclerotic lesion complexity without abrogating foam cell formation in hyperlipidemic mice. Arterioscler Thromb Vasc Biol 29: 19-26.
44. Matsumoto A, Naito M, Itakura H, Ikemoto S, Asaoka H, Hayakawa I, et al. (1990). Human macrophage scavenger receptors: primary structure, expression, and localization in atherosclerotic lesions. Proc Natl Acad Sci U S A 87: 9133-9137.
45. Mietus-Snyder M, Gowri MS, Pitas RE, (2000). Class A scavenger receptor up-regulation in smooth muscle cells by oxidized low density lipoprotein. Enhancement by calcium flux and concurrent cyclooxygenase-2 up-regulation. J Biol Chem 275: 17661-17670.
46. Mommaas-Kienhuis AM, van der Schroeff JG, Wijsman MC, Daems WT, Vermeer BJ, (1985). Conjugates of colloidal gold with native and acetylated low density lipoproteins for ultrastructural investigations on receptor-mediated endocytosis by cultured human monocyte-derived macrophages. Histochemistry 83: 29-35.
47. Moore KJ, Kunjathoor VV, Koehn SL, Manning JJ, Tseng AA, Silver JM, et al. (2005). Loss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic mice. J Clin Invest 115: 2192-2201.
48. Murphy JE, Tedbury PR, Homer-Vanniasinkam S, Walker JH, Ponnambalam S, (2005). Biochemistry and cell biology of mammalian scavenger receptors. Atherosclerosis 182: 1-15.
49. Nakamura T, Suzuki H, Wada Y, Kodama T, Doi T, (2006). Fucoidan induces nitric oxide production via p38 mitogen-activated protein kinase and NF-kappaB-dependent signaling pathways through macrophage scavenger receptors. Biochem Biophys Res Commun 343: 286-294.
50. Pawson AJ, Sharman JL, Benson HE, Faccenda E, Alexander SP, Buneman OP, et al.; NC-IUPHAR (2014). The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledge base of drug targets and their ligands. Nucl Acids Res 42 (Database Issue): D1098-D1106.
51. Pluddemann A, Neyen C, Gordon S, (2007). Macrophage scavenger receptors and host-derived ligands. Methods 43: 207-217.
52. Prabhudas M, Bowdish D, Drickamer K, Febbraio M, Herz J, Kobzik L, et al. (2014). Standardizing scavenger receptor nomenclature. J Immunol 192: 1997-2006.
53. Ren D, Wang X, Ha T, Liu L, Kalbfleisch J, Gao X, et al. (2013). SR-A deficiency reduces myocardial ischemia/reperfusion injury; involvement of increased microRNA-125b expression in macrophages. Biochim Biophys Acta 1832: 336-346.
54. Robbins CS, Hilgendorf I, Weber GF, Theurl I, Iwamoto Y, Figueiredo JL, et al. (2013). Local proliferation dominates lesional macrophage accumulation in atherosclerosis. Nat Med 19: 1166-1172.
55. Rohrer L, Freeman M, Kodama T, Penman M, Krieger M, (1990). Coiled-coil fibrous domains mediate ligand binding by macrophage scavenger receptor type II. Nature 343: 570-572.
56. Sano H, Ishino M, Kramer H, Shimizu T, Mitsuzawa H, Nishitani C, et al. (2007). The microtubule-binding protein Hook3 interacts with a cytoplasmic domain of scavenger receptor A. J Biol Chem 282: 7973-7981.
57. Segers FM, Yu H, Molenaar TJ, Prince P, Tanaka T, van Berkel TJ, et al. (2012). Design and validation of a specific scavenger receptor class AI binding peptide for targeting the inflammatory atherosclerotic plaque. Arterioscler Thromb Vasc Biol 32: 971-978.
58. Segers FM, den Adel B, Bot I, van der Graaf LM, van der Veer EP, Gonzalez W, et al. (2013). Scavenger receptor-AI-targeted iron oxide nanoparticles for in vivo MRI detection of atherosclerotic lesions. Arterioscler Thromb Vasc Biol 33: 1812-1819.
59. Seimon TA, Obstfeld A, Moore KJ, Golenbock DT, Tabas I, (2006). Combinatorial pattern recognition receptor signaling alters the balance of life and death in macrophages. Proc Natl Acad Sci U S A 103: 19794-19799.
60. Sugano R, Yamamura T, Harada-Shiba M, Miyake Y, Yamamoto A, (2001). Uptake of oxidized low-density lipoprotein in a THP-1 cell line lacking scavenger receptor A. Atherosclerosis 158: 351-357.
61. Suzuki H, Kurihara Y, Takeya M, Kamada N, Kataoka M, Jishage K, et al. (1997). A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection. Nature 386: 292-296.
62. Tsubamoto Y, Yamada N, Watanabe Y, Inaba T, Shiomi M, Shimano H, et al. (1994). Dextran sulfate, a competitive inhibitor for scavenger receptor, prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbits. Atherosclerosis 106: 43-50.
63. Tsujita K, Kaikita K, Hayasaki T, Honda T, Kobayashi H, Sakashita N, et al. (2007). Targeted deletion of class A macrophage scavenger receptor increases the risk of cardiac rupture after experimental myocardial infarction. Circulation 115: 1904-1911.
64. Van Eck M, De Winther MP, Herijgers N, Havekes LM, Hofker MH, Groot PH, et al. (2000). Effect of human scavenger receptor class A overexpression in bone marrow-derived cells on cholesterol levels and atherosclerosis in ApoE-deficient mice. Arterioscler Thromb Vasc Biol 20: 2600-2606.
65. Wang X, Zheng Y, Xu Y, Ben J, Gao S, Zhu X, et al. (2009). A novel peptide binding to the cytoplasmic domain of class A scavenger receptor reduces lipid uptake in THP-1 macrophages. Biochim Biophys Acta 1791: 76-83.
66. Whitman SC, Rateri DL, Szilvassy SJ, Cornicelli JA, Daugherty A, (2002). Macrophage-specific expression of class A scavenger receptors in LDL receptor(-/-) mice decreases atherosclerosis and changes spleen morphology. J Lipid Res 43: 1201-1208.
67. de Winther MP, Gijbels MJ, van Dijk KW, van Gorp PJ, Suzuki H, Kodama T, et al. (1999). Scavenger receptor deficiency leads to more complex atherosclerotic lesions in APOE3Leiden transgenic mice. Atherosclerosis 144: 315-321.
68. Xu Y, Qian L, Zong G, Ma K, Zhu X, Zhang H, et al. (2012). Class A scavenger receptor promotes cerebral ischemic injury by pivoting microglia/macrophage polarization. Neuroscience 218: 35-48.
69. Yi H, Yu X, Gao P, Wang Y, Baek SH, Chen X, et al. (2009). Pattern recognition scavenger receptor SRA/CD204 down-regulates Toll-like receptor 4 signaling-dependent CD8 T-cell activation. Blood 113: 5819-5828.
70. Yu X, Yi H, Guo C, Zuo D, Wang Y, Kim HL, et al. (2011). Pattern recognition scavenger receptor CD204 attenuates Toll-like receptor 4-induced NF-kappaB activation by directly inhibiting ubiquitination of tumor necrosis factor (TNF) receptor-associated factor 6. J Biol Chem 286: 18795-18806.
71. Zhao Z, de Beer MC, Cai L, Asmis R, de Beer FC, de Villiers WJ, et al. (2005). Low-density lipoprotein from apolipoprotein E-deficient mice induces macrophage lipid accumulation in a CD36 and scavenger receptor class A-dependent manner. Arterioscler Thromb Vasc Biol 25: 168-173.
72. Zhu X, Zong G, Zhu L, Jiang Y, Ma K, Zhang H, et al. (2014). Deletion of class A scavenger receptor deteriorates obesity-induced insulin resistance in adipose tissue. Diabetes 63: 562-577.
73. Zhu XD, Zhuang Y, Ben JJ, Qian LL, Huang HP, Bai H, et al. (2011). Caveolae-dependent endocytosis is required for class A macrophage scavenger receptor-mediated apoptosis in macrophages. J Biol Chem 286: 8231-8239.